• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Pupils can be pharmacologically dilated after death, study finds



Seattle-Meaningful pharmacological dilation of pupils is possible after death, according to results from a new study conducted at the University of South Florida.

Fourteen eyes were obtained by the Lions Eye Institute for Transplant & Research (LEITR) between December 2012 and April 2013. LEITR inspected the eyes for iris color and signs of abnormalities and reviewed pre-death patient histories. None of the eyes were excluded due to a prior history of iris surgery, iris trauma, iris melanoma, iritis, or iridoschisis.

At study onset, images of the pupils were recorded on a digital camera, and then two drops of a solution of 10% phenylephrine and 1% tropicamide were placed on the surface of the corneas. Seven of the eyes received drops pre-procurement and seven post-procurement. The set of drops was repeated twice, every 3 minutes. Pupils were then measured at 20 minutes and at 60 minutes with a millimeter ruler and recorded on a digital camera for future analysis.

The findings showed that effective pupillary dilation was achieved up to 24 hours after death. Pupil dilation from 0.7mm to 2.6mm was measured and seen across a range of iris colors both pre- and post- tissue procurement.ODT

Related Videos
Andy Morgenstern, OD, FAAO, FNAP chats with Optometry Times
R Tracy Williams, OD, FAAO with Optometry Times
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Cecelia Koetting, OD, FAAO, DIPABO, left, speaks with Optometry Times about the 2024 EnVision Summit
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Robert Weiss, former CEO and President of The Cooper Companies, Inc. (left) and Optometry Times' Assistant Managing Editor Emily Kaiser Maharjan Image Credit ©Optometry Times
© 2024 MJH Life Sciences

All rights reserved.